Hodgson S, Hart K, Abbs S, Heckmatt J, Rodillo E, Bobrow M, Dubowitz V
Paediatric Research Unit, United Medical School, Guy's Hospital, London.
J Med Genet. 1989 Nov;26(11):682-93. doi: 10.1136/jmg.26.11.682.
Cloned cDNA sequences representing exons from the Duchenne/Becker muscular dystrophy (DMD/BMD) gene were used for deletion screening in a population of 287 males males affected with DMD or BMD. The clinical phenotypes of affected boys were classified into three clinical severity groups based on the age at which ambulation was lost. Boys in group 1 had DMD, losing ambulation before their 13th birthday; those in group 2 had disease of intermediate severity, losing ambulation between the ages of 13 and 16 years; and boys in group 3 had BMD, being ambulant beyond 16 years. A fourth group consisted of patients too young to be classified. Clinical group allocation was made without previous knowledge of the DNA results. A gene deletion was found in 124 cases where the clinical severity group of the affected boy was known. The extent of the deletions was delineated using cDNA probes. There were 74 different deletions. Fifty-five of these were unique to individual patients, but the other 19 were found in at least two unrelated patients. The different clinical groups showed generally similar distributions of deletions, and the number of exon bands deleted (that is, deletion size) was independent of phenotype. Some specific deletion types, however, correlated with the clinical severity of the disease. Deletion of exons containing HindIII fragments 33 and 34 and 33 to 35 were associated with BMD and were not found in patients with DMD. Deletions 3 to 7 occurred in four patients with the intermediate phenotype and one patient with BMD. Other shared deletions were associated with DMD, although in four cases patients with disease of intermediate severity apparently shared the same deletion with boys with DMD. The range of phenotypes observed, and the overlap at the genetic level between severe and intermediate and mild and intermediate forms of dystrophy, emphasizes the essential continuity of the clinical spectrum of DMD/BMD. There were no characteristic deletions found in boys with mental retardation or short stature which differed from deletions in affected boys without these features.
代表杜兴/贝克型肌营养不良症(DMD/BMD)基因外显子的克隆cDNA序列,被用于对287名患有DMD或BMD的男性群体进行缺失筛查。根据失去行走能力的年龄,将患病男孩的临床表型分为三个临床严重程度组。第1组男孩患有DMD,在13岁生日前失去行走能力;第2组男孩患有中度严重程度的疾病,在13至16岁之间失去行走能力;第3组男孩患有BMD,16岁以后仍能行走。第四组由年龄太小而无法分类的患者组成。临床组分配是在不知道DNA结果的情况下进行的。在124例已知患病男孩临床严重程度组的病例中发现了基因缺失。使用cDNA探针描绘了缺失的范围。共有74种不同的缺失。其中55种是个别患者特有的,但另外19种在至少两名无亲缘关系的患者中被发现。不同的临床组显示出大致相似的缺失分布,并且缺失的外显子带数量(即缺失大小)与表型无关。然而,一些特定的缺失类型与疾病的临床严重程度相关。包含HindIII片段33和34以及33至35的外显子缺失与BMD相关,在DMD患者中未发现。缺失3至7发生在4例具有中度表型的患者和1例BMD患者中。其他共享缺失与DMD相关,尽管在4例中,中度严重程度疾病的患者显然与DMD男孩共享相同的缺失。观察到的表型范围,以及严重、中度和轻度与中度肌营养不良症在基因水平上的重叠,强调了DMD/BMD临床谱的本质连续性。在患有智力障碍或身材矮小的男孩中未发现与没有这些特征的患病男孩的缺失不同的特征性缺失。